Literature DB >> 3435174

Antiendomysial antibody--useful serological indicator of dermatitis herpetiformis.

V Kumar1, E H Beutner, T P Chorzelski.   

Abstract

Antiendomysial antibodies (EmA) of the IgA class are directed against reticulin components of the primate smooth muscle and are markers of gluten-sensitive enteropathy. These antibodies occur in essentially all active cases of celiac disease and in about 70% of dermatitis herpetiformis (DH) patients. IgA deposits in the dermal papillae of the skin are the hallmark of DH and are employed routinely in establishing its diagnosis. The incidence of IgA deposits in skin varies depending upon the site and type of biopsy specimen taken. We studied sera and skin biopsy specimens for EmA and for IgA deposits in the skin from 11 DH patients. EmA were detected in the sera of 10 of the 11 cases. Of these 11 patients, 9 were positive for IgA deposits in their skin, as revealed by direct immunofluorescence (IF). The immune deposits were detected in the normal, and not in the lesional skin. DH cases that were initially negative on biopsy and serum positive for EmA were found to be positive when a repeat biopsy of the normal skin was performed. Thus, serological studies in conjunction with direct IF studies of the normal skin are useful in making a diagnosis of DH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435174     DOI: 10.1007/BF00412591

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Immunoglobulins in the skin in dermatitis herpetiformis and their relevance in diagnosis.

Authors:  P P Seah; L Fry
Journal:  Br J Dermatol       Date:  1975-02       Impact factor: 9.302

2.  Sensitivity and specificity of IgA-class antiendomysial antibodies for dermatitis herpetiformis and findings relevant to their pathogenic significance.

Authors:  E H Beutner; T P Chorzelski; V Kumar; J Leonard; S Krasny
Journal:  J Am Acad Dermatol       Date:  1986-09       Impact factor: 11.527

3.  Detection of antigliadin antibodies in bullous diseases and their recognition of similar antigenic polypeptides.

Authors:  V Kumar; N Jain; E H Beutner; T P Chorzelski
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

4.  Dermatitis herpetiformis: an evaluation of diagnostic criteria.

Authors:  L Fry; P P Seah
Journal:  Br J Dermatol       Date:  1974-02       Impact factor: 9.302

5.  Immunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid.

Authors:  T P Chorzelski; E H Beutner; S Jablonska; M Blaszczyk; C Triftshauser
Journal:  J Invest Dermatol       Date:  1971-05       Impact factor: 8.551

6.  Tissue antibodies in dermatitis herpetiformis and adult coeliac disease.

Authors:  P P Seah; L Fry; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

7.  Disease specificity and dynamics of changes in IgA class anti-endomysial antibodies in celiac disease.

Authors:  A Kapuscinska; T Zalewski; T P Chorzelski; J Sulej; E H Beutner; V Kumar; T Rossi
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Jul-Aug       Impact factor: 2.839

8.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

9.  IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge.

Authors:  J N Leonard; T P Chorzelski; E H Beutner; J Sulej; C E Griffiths; V J Kumar; L Fry
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

10.  Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion.

Authors:  H Moi
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.